North America is projected to dominate transcatheter mitral valve repair and replacement
market, owing to high prevalence of cardiac disease. For instance, in the U.S., heart disease is
a leading cause of death, accounting for around 375,000 deaths annually. According to
ClinicoEconomics and Outcomes Research 2016, Mitral regurgitation is the most frequent valve
disease in the U.S. affecting nearly 1 in 10 people of 75 years or older.
Asia Pacific region is expected to witness significant growth, owing expansions of manufacturing
facilities by market players. For instance, Medtronic, Inc. in March 2011, opened new
manufacturing facility in Singapore to meet increasing demand for cardiac devices in region.
Transcatheter Mitral Valve Repair and Replacement Market – Competitive Analysis
The key players operating in the global transcatheter mitral valve repair and replacement
devices market include Abbott Laboratories, Biotronik Private Limited, Colibri Heart Valve,
Edward Lifesciences Corporation, HLT Medical, LivaNova Plc, Medtronic Plc, Neovasc Inc., and
NeoChord.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com